| 원격전이 및 재발된 두경부 악성종양 ( 편평상피암 ) 에 대한 5-FU Infusion 및 Cisplatin ( FP ) 복합 화학요법 |
| 이재훈, 윤성수, 강윤구, 김승택, 방영주, 김노경, 김광현, 민양기, 박찬일 |
|
| 5-FU Infusion and Cisplatin in Patients with Disseminated or Recurrent Head and Neck Cancer |
| Jae Hoon Lee, Sung Soo Yoon, Keun Chil Park, Seung Taek Kim, Yung Jue Bang, Noe Kyeong Kim, Kwang Hyun Kim, Yang Gi Min, Charn Il Park |
|
|
|
|
|
|
|
| ABSTRACT |
|
56 patients with dissminated or recurrent head and neck cancer were treated with 5-FU infusion and cisplatin between July, 1983 and June, 1986. The results were as follows; 1) Among 54 evaluable patients, response rate was 48.1% (complete responses 7.4% partial responses 40.7%).Response rates of disseminated and recurrent group were 88.9% and 40%, respectively (p<0. 05). 2) Median time to disease progression was 4.4 months for overall patients, and 7.5 months and 2. 9 month for responders and nonresponders; there was statistically significant difference (P<0.05). 3) Median survival was 15.3 month for overall patients and 24.5 month and 9.2 month for responders and nonresponders; there was statistically significant difference (P<0.05). 4) Nausea and vomitting were observed in all patients but easily controlled, and stomatitis, alopecia, diarrhea were obrerved infrequently, 1eukopenia and thrombocytopenia were observed in 25, 9% and 1, 9%, In conclusion, combination chemotherapy with 5 FV infusion and cisplatin in patients with disseninated or recurrent head and neck cancer seemed to be relatively effective and well tolerable. |
|
PDF Links
Full text via DOI 
Download Citation 
CrossRef TDM
